Fenel M Eloi
CIK 1237190 · View on SEC EDGAR ↗
First SEC filing: June 12, 2026 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | A | 175,923 | — | — | 175,923 Direct | — | Acquired | (price as of 2026-08-19) |
| June 18, 2026 | LAB | A | 99,116 | — | — | 335,299 Direct | +41.97% | Acquired | (price as of 2026-08-19) |
| June 11, 2026 | MASS | A | 6,209 | — | — | 6,209 Direct | — | Acquired | (price as of 2026-08-19) |
| June 11, 2026 | MASS | A | 13,656 | — | — | 13,656 Direct | — | Acquired | (price as of 2026-08-19) |
| June 10, 2026 | MASS | M | 14,083 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-19) |
| June 10, 2026 | MASS | M | 14,083 | — | — | 40,897 Direct | +52.52% | Acquired | (price as of 2026-08-19) |
| June 20, 2025 | LAB | A | 125,660 | — | — | 125,660 Direct | — | Acquired | (price as of 2026-08-19) |
| June 20, 2025 | LAB | A | 94,592 | — | — | 236,183 Direct | +66.81% | Acquired | (price as of 2026-08-19) |
| June 28, 2024 | LAB | A | 72,213 | — | — | 72,213 Direct | — | Acquired | (price as of 2026-08-19) |
| June 28, 2024 | LAB | A | 43,128 | — | — | 141,591 Direct | +43.80% | Acquired | (price as of 2026-08-19) |
| June 14, 2023 | LAB | A | 35,380 | — | — | 35,380 Direct | — | Acquired | (price as of 2026-08-19) |
| June 14, 2023 | LAB | A | 26,376 | — | — | 98,463 Direct | +36.59% | Acquired | (price as of 2026-08-19) |
| March 15, 2023 | LAB | A | 72,087 | — | — | 72,087 Direct | — | Acquired | (price as of 2026-08-19) |
| June 17, 2021 | MASS | A | 1,379 | — | — | 1,379 Direct | — | Acquired | (price as of 2026-08-19) |
| June 17, 2021 | MASS | A | 2,455 | — | — | 2,455 Direct | — | Acquired | (price as of 2026-08-19) |
| March 1, 2021 | MASS | A | 1,523 | — | — | 1,523 Direct | — | Acquired | (price as of 2026-08-19) |
| March 1, 2021 | MASS | A | 2,562 | — | — | 2,562 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | Stock Option (Right to buy) | Common Stock (175,923) | $0.83 | June 18, 2036 | 175,923 | Acquired |
| June 11, 2026 | MASS | Stock Option (option to buy) | Common Stock (6,209) | $8.22 | June 10, 2036 | 6,209 | Acquired |
| June 11, 2026 | MASS | Restricted Stock Units | Common Stock (13,656) | — | — | 13,656 | Acquired |
| June 10, 2026 | MASS | Restricted Stock Units | Common Stock (14,083) | — | — | 14,083 | Disposed |
| June 20, 2025 | LAB | Stock Option (Right to buy) | Common Stock (125,660) | $1.05 | June 20, 2035 | 125,660 | Acquired |
| June 28, 2024 | LAB | Stock Option (Right to buy) | Common Stock (72,213) | $1.77 | June 28, 2034 | 72,213 | Acquired |
| June 14, 2023 | LAB | Stock Option (Right to Buy) | Common Stock (35,380) | $2.18 | June 14, 2033 | 35,380 | Acquired |
| June 17, 2021 | MASS | Restricted Stock Unit | Common Stock, par value $0.001 (1,379) | — | — | 1,379 | Acquired |
| June 17, 2021 | MASS | Stock Option (option to buy) | Common Stock, par value $0.001 (2,455) | $41.70 | June 17, 2031 | 2,455 | Acquired |
| March 1, 2021 | MASS | Restricted Stock Unit | Common Stock, par value $0.001 (1,523) | — | — | 1,523 | Acquired |
| March 1, 2021 | MASS | Stock Option (option to buy) | Common Stock, par value $0.001 (2,562) | $57.47 | March 1, 2031 | 2,562 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).